ANA-12

From WikiMD's WELLNESSPEDIA

Chemical structure of ANA-12

ANA-12 is a small molecule that acts as a selective antagonist of the tropomyosin receptor kinase B (TrkB), which is the high-affinity receptor for brain-derived neurotrophic factor (BDNF). ANA-12 is of interest in the field of neuroscience and pharmacology due to its potential therapeutic applications in neurological disorders and psychiatric disorders.

Mechanism of Action[edit]

ANA-12 functions by selectively inhibiting the activity of TrkB receptors. TrkB is a member of the neurotrophin receptor family and is primarily activated by BDNF. The binding of BDNF to TrkB initiates a cascade of intracellular signaling pathways that are crucial for neuronal survival, synaptic plasticity, and cognitive function. By antagonizing TrkB, ANA-12 can modulate these pathways, which may be beneficial in conditions where BDNF signaling is dysregulated.

Potential Therapeutic Applications[edit]

Research into ANA-12 has suggested several potential therapeutic applications:

  • Depression: Dysregulation of BDNF and TrkB signaling has been implicated in the pathophysiology of depression. ANA-12, by modulating this pathway, may offer a novel approach to treating depression.
  • Anxiety disorders: Similar to depression, anxiety disorders may involve altered BDNF signaling. ANA-12 could potentially be used to address these alterations.

Research and Development[edit]

ANA-12 is primarily used in preclinical research settings. Studies have demonstrated its ability to cross the blood-brain barrier, making it a valuable tool for in vivo studies of TrkB function. Ongoing research is focused on understanding the full range of its effects and potential side effects in various models of disease.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=ANA-12&oldid=6622620"